10.1080/00958972.2010.534140
The research focuses on the synthesis, characterization, and evaluation of the antitumor and cytotoxic activities of a series of mononuclear Ru(II) complexes, specifically [Ru(T)2(S)]2t, where T represents 2,2'-bipyridine or 1,10-phenanthroline, and S denotes various thiosemicarbazone derivatives such as CH3-bitsz, Cl-bitsz, Br-bitsz, tmtsz, and dmtsz. The reactants used in the synthesis include hydrated ruthenium trichloride, 2,2'-bipyridine, 1,10-phenanthroline, and the thiosemicarbazone ligands. The complexes were characterized using UV-Vis, IR, 1H-NMR, FAB-mass spectroscopy, and elemental analysis. The antitumor activity was assessed in vivo against a transplantable murine tumor cell line (Ehrlich’s ascitic carcinoma), and the cytotoxic activity was evaluated in vitro against human cancer cell lines (Molt 4/C8 and CEM) and a murine tumor cell line (L1210). The study aimed to develop potential cytotoxins and explore the antitumor properties of these Ru(II) complexes as alternatives to platinum-based drugs, which are known for their high toxicity.
10.1016/j.ejmech.2010.03.026
The research focused on the synthesis and evaluation of antitumor activity of thiosemicarbazones derived from the natural sesquiterpene (±)-α-bisabolol against a panel of eight human tumor cell lines. The purpose was to assess their potential as anti-cancer agents and to identify structure-activity relationships that contribute to their antitumor activity. The study concluded that some of the synthesized compounds, particularly the ketone derivative 3l, exhibited potent antitumor activity and high selectivity for myeloid leukemia cells (K-562), with compound 3l showing superior activity compared to the standard drug doxorubicin. The chemicals used in the process included (±)-α-bisabolol, isothiocyanate, hydrazine, and various benzaldehyde derivatives, as well as acetophenone or benzophenone, with catalytic amounts of sulfuric acid used in the reaction. The synthesized thiosemicarbazones were then tested for their inhibitory effects on cancer cell growth, leading to the identification of structural requirements for enhanced antitumor activity.